1262 — Labixiaoxin Snacks Income Statement
0.000.00%
- HK$581.38m
- HK$1.11bn
- CNY969.81m
Annual income statement for Labixiaoxin Snacks, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 648 | 684 | 764 | 867 | 970 |
| Cost of Revenue | |||||
| Gross Profit | 224 | 244 | 219 | 235 | 266 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 601 | 725 | 846 | 940 | 939 |
| Operating Profit | 47.5 | -40.3 | -82.1 | -73.3 | 30.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 17 | -67.7 | -105 | -93.5 | 12.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -65.2 | -75.3 | -105 | -93.5 | 11.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -65.2 | -75.3 | -105 | -93.5 | 11.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -65.2 | -75.3 | -105 | -93.5 | 11.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.56 | -0.47 | -0.657 | -0.506 | 0.067 |